Related Experiment Video
Updated: Aug 14, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
RPN2 in cancer: An overview
Zhengxuan Han1, You Wang2, Lei Han1
1Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China; Hubei Key Laboratory of Tumour Biological Behaviours, Wuhan, China; Hubei Cancer Clinical Study Center, Wuhan, China; The Clinical Medical Research Center of Peritoneal Cancer of Wuhan, Wuhan, China.
RPN2 is an oncogene crucial for cancer development, promoting tumor growth, metastasis, and drug resistance. Understanding its role enhances cancer prognosis and therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Oncogenes and tumor suppressor genes regulate cancer phenotypes.
- RPN2, an oncogene, encodes a protein involved in N-oligosaccharyl transferase, and its aberrant expression is noted in human malignancies.
Purpose of the Study:
- To review the functions and clinical significance of RPN2 in cancer.
- To enhance understanding of RPN2's role in tumorigenicity, metastasis, progression, and multi-drug resistance.
Main Methods:
- Literature review of studies on RPN2 in human cancers.
- Analysis of RPN2's involvement in N-glycosylation and signaling pathways.
Main Results:
- RPN2 contributes to tumor progression, metastasis, and multi-drug resistance.
- RPN2 is implicated in N-glycosylation and regulates multiple signaling pathways.
- RPN2 demonstrates prognostic value and serves as a therapeutic target.
Conclusions:
- RPN2 is a significant oncogene with diverse roles in cancer progression.
- RPN2 holds promise as a biomarker for cancer prognosis and therapy efficacy.
More Related Videos
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Abnormal Proliferation